Expert Rev Endocrinol Metab. 2013;8(2):183-193. Mitotane reduces cortisol synthesis through the inhibition of 11B-hydroxylase, 18-hydroxylase, 3-α hydroxylase, hydroxysteroid dehydrogenase and several ...
Extremely high cortisol levels (Cushing's syndrome) can lead to treatment-resistant high blood pressure. Learn how this ...
Cushing’s syndrome is a challenging endocrine disorder caused by prolonged excess cortisol, often requiring precise nursing strategies. Recognizing hallmark signs like moon face and truncal obesity, ...
Cushing's syndrome, defined by chronic cortisol excess, is well established as a disorder with multisystem implications. One of its critical complications is a hypercoagulable state that significantly ...
Cushing's syndrome and its pituitary variant, Cushing's disease, represent complex endocrine disorders characterised by chronic excessive glucocorticoid exposure. This hypercortisolaemia may be the ...
The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...
Mifepristone is a generic drug that is available as an oral tablet. It’s typically taken once per day with a meal. For Cushing syndrome, mifepristone works by blocking cortisol receptors, which helps ...
Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.